ADHD - Attention Deficit Disorder With Hyperactivity: Clinical Trials

2 trials for ADHD - Attention Deficit Disorder With Hyperactivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 2

Follow ADHD - Attention Deficit Disorder With Hyperactivity: new trials by email Literature Review of ADHD - Attention Deficit Disorder With Hyperactivity trials Research Report on ADHD - Attention Deficit Disorder With Hyperactivity

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Medication Treatment of ADHD in Pediatric Epilepsy
methylphenidate hydrochloride (Jornay PM) - ADHD - Attention Deficit Disorder With Hyperactivity
Phase 4RecruitingHugo W. Moser Research Institute at Kennedy Krieger, Inc.252026-05-292026-07-29
Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants
CNS Stimulant, Placebo, CNS Stimulant open label first phase - ADHD - Attention Deficit Disorder With Hyperactivity, Irritability
Phase 4RecruitingMilton S. Hershey Medical Center1362026-03-052026-04-20

Narrower conditions

Attention Deficit Disorder with Hyperactivity (2)  ·  Aggression (1)  ·  Epilepsy (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (2)  ·  Mental Disorders (2)  ·  Neurodevelopmental Disorders (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Nervous System Diseases (1)  ·  Social Behavior (1)

Interventions

Central Nervous System Stimulants (1)  ·  Clinical Trials, Phase II as Topic (1)  ·  Methylphenidate (1)

Sponsors

Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1)  ·  Milton S. Hershey Medical Center (1)

Countries

United States (2)

Top investigators

Jay Salpekar, MD (1)